Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
Article number e12902
JournalDermatologic Therapy
Volume32
Issue number3
Number of pages2
ISSN1396-0296
DOIs
Publication statusPublished - 2019

ID: 226113285